The present study is a double-blinded randomized clinical trial with a duration of 12 weeks.
The present study is a double-blinded randomized clinical trial with a duration of 12 weeks . 60 patients with periodontitis stage 2-3, grade B-C, generalized will be allocated in the test (probiotic) and the control (placebo) group at baseline. The intervention is non-surgical periodontal treatment, which will be applied at baseline and followed for 12 weeks. Clinical measurements and sampling will be performed at baseline, week 6 and week 12. Primary endpoint: Changes in microbial composition. Secondary endpoints: Changes in clinical and immunological parameters
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
60
University of Copenhagen, Department of Odontology
Copenhagen, Denmark
RECRUITINGChanges in microbial composition in dental plaque
Changes in alpha and beta diversity of microbial composition
Time frame: Baseline vs. week 6 and week 12
Changes in dental plaque
Changes in mean level of dental plaque
Time frame: Baseline vs. week 6 and week 12
Changes in bleeding on probing
Changes in mean level of bleeding on probing
Time frame: Baseline vs. week 6 and week 12
Changes in probing pocket depth
Changes in mean level of probing pocket depth
Time frame: Baseline vs. week 6 and week 12
Changes in clinical attachment level
Changes in mean level of clinical attachment level
Time frame: Baseline vs. week 6 and week 12
Changes in salivary levels of inflammatory cytokines
Changes in mean salivary levels of selected inflammatory cytokines
Time frame: Baseline vs. week 6 and week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.